Global and Japan Plasma Fractionation and Blood Product Market Insights, Forecast to 2027

Report ID: 1015037 | Published Date: Jan 2025 | No. of Page: 148 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Plasma Fractionation and Blood Product Product Introduction
    1.2 Market by Type
        1.2.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type
        1.2.2 Coagulation Factor
        1.2.3 Immune Globulin
        1.2.4 Albumin
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application
        1.3.2 Immunology
        1.3.3 Hematology
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Plasma Fractionation and Blood Product Market Size, Estimates and Forecasts
        2.1.1 Global Plasma Fractionation and Blood Product Revenue 2016-2027
        2.1.2 Global Plasma Fractionation and Blood Product Sales 2016-2027
    2.2 Global Plasma Fractionation and Blood Product, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Plasma Fractionation and Blood Product Historical Market Size by Region (2016-2021)
        2.3.1 Global Plasma Fractionation and Blood Product Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Plasma Fractionation and Blood Product Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Plasma Fractionation and Blood Product Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Plasma Fractionation and Blood Product Sales Forecast by Region (2022-2027)
        2.4.2 Global Plasma Fractionation and Blood Product Revenue Forecast by Region (2022-2027)

3 Global Plasma Fractionation and Blood Product Competitor Landscape by Players
    3.1 Global Top Plasma Fractionation and Blood Product Manufacturers by Sales
        3.1.1 Global Plasma Fractionation and Blood Product Sales by Manufacturer (2016-2021)
        3.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Plasma Fractionation and Blood Product Manufacturers by Revenue
        3.2.1 Key Plasma Fractionation and Blood Product Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2016-2021)
        3.2.3 Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Plasma Fractionation and Blood Product Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Plasma Fractionation and Blood Product Revenue in 2020
        3.2.6 Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Plasma Fractionation and Blood Product Price by Manufacturers
    3.4 Global Plasma Fractionation and Blood Product Manufacturing Base Distribution, Product Types
        3.4.1 Plasma Fractionation and Blood Product Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Plasma Fractionation and Blood Product Product Type
        3.4.3 Date of International Manufacturers Enter into Plasma Fractionation and Blood Product Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Plasma Fractionation and Blood Product Market Size by Type (2016-2021)
        4.1.1 Global Plasma Fractionation and Blood Product Sales by Type (2016-2021)
        4.1.2 Global Plasma Fractionation and Blood Product Revenue by Type (2016-2021)
        4.1.3 Plasma Fractionation and Blood Product Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Plasma Fractionation and Blood Product Market Size Forecast by Type (2022-2027)
        4.2.1 Global Plasma Fractionation and Blood Product Sales Forecast by Type (2022-2027)
        4.2.2 Global Plasma Fractionation and Blood Product Revenue Forecast by Type (2022-2027)
        4.2.3 Plasma Fractionation and Blood Product Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Plasma Fractionation and Blood Product Market Size by Application (2016-2021)
        5.1.1 Global Plasma Fractionation and Blood Product Sales by Application (2016-2021)
        5.1.2 Global Plasma Fractionation and Blood Product Revenue by Application (2016-2021)
        5.1.3 Plasma Fractionation and Blood Product Price by Application (2016-2021)
    5.2 Plasma Fractionation and Blood Product Market Size Forecast by Application (2022-2027)
        5.2.1 Global Plasma Fractionation and Blood Product Sales Forecast by Application (2022-2027)
        5.2.2 Global Plasma Fractionation and Blood Product Revenue Forecast by Application (2022-2027)
        5.2.3 Global Plasma Fractionation and Blood Product Price Forecast by Application (2022-2027)

6 Japan by Players, Type and Application
    6.1 Japan Plasma Fractionation and Blood Product Market Size YoY Growth 2016-2027
        6.1.1 Japan Plasma Fractionation and Blood Product Sales YoY Growth 2016-2027
        6.1.2 Japan Plasma Fractionation and Blood Product Revenue YoY Growth 2016-2027
        6.1.3 Japan Plasma Fractionation and Blood Product Market Share in Global Market 2016-2027
    6.2 Japan Plasma Fractionation and Blood Product Market Size by Players (International and Local Players)
        6.2.1 Japan Top Plasma Fractionation and Blood Product Players by Sales (2016-2021)
        6.2.2 Japan Top Plasma Fractionation and Blood Product Players by Revenue (2016-2021)
    6.3 Japan Plasma Fractionation and Blood Product Historic Market Review by Type (2016-2021)
        6.3.1 Japan Plasma Fractionation and Blood Product Sales Market Share by Type (2016-2021)
        6.3.2 Japan Plasma Fractionation and Blood Product Revenue Market Share by Type (2016-2021)
        6.3.3 Japan Plasma Fractionation and Blood Product Price by Type (2016-2021)
    6.4 Japan Plasma Fractionation and Blood Product Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 Japan Plasma Fractionation and Blood Product Sales Forecast by Type (2022-2027)
        6.4.2 Japan Plasma Fractionation and Blood Product Revenue Forecast by Type (2022-2027)
        6.4.3 Japan Plasma Fractionation and Blood Product Price Forecast by Type (2022-2027)
    6.5 Japan Plasma Fractionation and Blood Product Historic Market Review by Application (2016-2021)
        6.5.1 Japan Plasma Fractionation and Blood Product Sales Market Share by Application (2016-2021)
        6.5.2 Japan Plasma Fractionation and Blood Product Revenue Market Share by Application (2016-2021)
        6.5.3 Japan Plasma Fractionation and Blood Product Price by Application (2016-2021)
    6.6 Japan Plasma Fractionation and Blood Product Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 Japan Plasma Fractionation and Blood Product Sales Forecast by Application (2022-2027)
        6.6.2 Japan Plasma Fractionation and Blood Product Revenue Forecast by Application (2022-2027)
        6.6.3 Japan Plasma Fractionation and Blood Product Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Plasma Fractionation and Blood Product Market Size YoY Growth 2016-2027
    7.2 North America Plasma Fractionation and Blood Product Market Facts & Figures by Country
        7.2.1 North America Plasma Fractionation and Blood Product Sales by Country (2016-2021)
        7.2.2 North America Plasma Fractionation and Blood Product Revenue by Country (2016-2021)
        7.2.3 United States
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Plasma Fractionation and Blood Product Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Plasma Fractionation and Blood Product Market Facts & Figures by Region
        8.2.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2016-2021)
        8.2.2 Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia

9 Europe
    9.1 Europe Plasma Fractionation and Blood Product Market Size YoY Growth 2016-2027
    9.2 Europe Plasma Fractionation and Blood Product Market Facts & Figures by Country
        9.2.1 Europe Plasma Fractionation and Blood Product Sales by Country (2016-2021)
        9.2.2 Europe Plasma Fractionation and Blood Product Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Plasma Fractionation and Blood Product Market Size YoY Growth 2016-2027
    10.2 Latin America Plasma Fractionation and Blood Product Market Facts & Figures by Country
        10.2.1 Latin America Plasma Fractionation and Blood Product Sales by Country (2016-2021)
        10.2.2 Latin America Plasma Fractionation and Blood Product Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Plasma Fractionation and Blood Product Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Plasma Fractionation and Blood Product Market Facts & Figures by Country
        11.2.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 Takeda
        12.1.1 Takeda Corporation Information
        12.1.2 Takeda Description and Business Overview
        12.1.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Takeda Plasma Fractionation and Blood Product Products Offered
        12.1.5 Takeda Recent Development
    12.2 CSL
        12.2.1 CSL Corporation Information
        12.2.2 CSL Description and Business Overview
        12.2.3 CSL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 CSL Plasma Fractionation and Blood Product Products Offered
        12.2.5 CSL Recent Development
    12.3 Grifols
        12.3.1 Grifols Corporation Information
        12.3.2 Grifols Description and Business Overview
        12.3.3 Grifols Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Grifols Plasma Fractionation and Blood Product Products Offered
        12.3.5 Grifols Recent Development
    12.4 Octapharma
        12.4.1 Octapharma Corporation Information
        12.4.2 Octapharma Description and Business Overview
        12.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Octapharma Plasma Fractionation and Blood Product Products Offered
        12.4.5 Octapharma Recent Development
    12.5 Kedrion
        12.5.1 Kedrion Corporation Information
        12.5.2 Kedrion Description and Business Overview
        12.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Kedrion Plasma Fractionation and Blood Product Products Offered
        12.5.5 Kedrion Recent Development
    12.6 LFB Group
        12.6.1 LFB Group Corporation Information
        12.6.2 LFB Group Description and Business Overview
        12.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 LFB Group Plasma Fractionation and Blood Product Products Offered
        12.6.5 LFB Group Recent Development
    12.7 Biotest
        12.7.1 Biotest Corporation Information
        12.7.2 Biotest Description and Business Overview
        12.7.3 Biotest Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Biotest Plasma Fractionation and Blood Product Products Offered
        12.7.5 Biotest Recent Development
    12.8 BPL
        12.8.1 BPL Corporation Information
        12.8.2 BPL Description and Business Overview
        12.8.3 BPL Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 BPL Plasma Fractionation and Blood Product Products Offered
        12.8.5 BPL Recent Development
    12.9 RAAS
        12.9.1 RAAS Corporation Information
        12.9.2 RAAS Description and Business Overview
        12.9.3 RAAS Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 RAAS Plasma Fractionation and Blood Product Products Offered
        12.9.5 RAAS Recent Development
    12.10 CBPO
        12.10.1 CBPO Corporation Information
        12.10.2 CBPO Description and Business Overview
        12.10.3 CBPO Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 CBPO Plasma Fractionation and Blood Product Products Offered
        12.10.5 CBPO Recent Development
    12.11 Takeda
        12.11.1 Takeda Corporation Information
        12.11.2 Takeda Description and Business Overview
        12.11.3 Takeda Plasma Fractionation and Blood Product Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Takeda Plasma Fractionation and Blood Product Products Offered
        12.11.5 Takeda Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Plasma Fractionation and Blood Product Industry Trends
    13.2 Plasma Fractionation and Blood Product Market Drivers
    13.3 Plasma Fractionation and Blood Product Market Challenges
    13.4 Plasma Fractionation and Blood Product Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Plasma Fractionation and Blood Product Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Coagulation Factor
    Table 3. Major Manufacturers of Immune Globulin
    Table 4. Major Manufacturers of Albumin
    Table 5. Major Manufacturers of Other
    Table 6. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 7. Global Plasma Fractionation and Blood Product Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 8. Global Plasma Fractionation and Blood Product Sales by Regions (2016-2021) & (K Units)
    Table 9. Global Plasma Fractionation and Blood Product Sales Market Share by Regions (2016-2021)
    Table 10. Global Plasma Fractionation and Blood Product Revenue by Regions (2016-2021) & (US$ Million)
    Table 11. Global Plasma Fractionation and Blood Product Sales Forecast by Region (2022-2027) & (K Units)
    Table 12. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Region (2022-2027)
    Table 13. Global Plasma Fractionation and Blood Product Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 14. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Region (2022-2027)
    Table 15. Global Plasma Fractionation and Blood Product Sales by Manufacturers (2016-2021) (K Units)
    Table 16. Global Plasma Fractionation and Blood Product Sales Share by Manufacturers (2016-2021)
    Table 17. Ranking of Global Top Plasma Fractionation and Blood Product Manufacturers by Revenue (US$ Million) in 2020
    Table 18. Plasma Fractionation and Blood Product Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 19. Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2016-2021)
    Table 20. Global Plasma Fractionation and Blood Product Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 21. Global Plasma Fractionation and Blood Product by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Fractionation and Blood Product as of 2020)
    Table 22. Key Manufacturers Plasma Fractionation and Blood Product Price (2016-2021) (US$/Unit)
    Table 23. Plasma Fractionation and Blood Product Manufacturers Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Plasma Fractionation and Blood Product Product Type
    Table 25. Date of International Manufacturers Enter into Plasma Fractionation and Blood Product Market
    Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 27. Global Plasma Fractionation and Blood Product Sales by Type (2016-2021) (K Units)
    Table 28. Global Plasma Fractionation and Blood Product Sales Share by Type (2016-2021)
    Table 29. Global Plasma Fractionation and Blood Product Revenue by Type (2016-2021) (US$ Million)
    Table 30. Global Plasma Fractionation and Blood Product Revenue Share by Type (2016-2021)
    Table 31. Plasma Fractionation and Blood Product Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 32. Global Plasma Fractionation and Blood Product Sales Forecast by Type (2022-2027) & (K Units)
    Table 33. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Type (2022-2027)
    Table 34. Global Plasma Fractionation and Blood Product Revenue Forecast V (2022-2027) & (US$ Million)
    Table 35. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Type (2022-2027)
    Table 36. Global Plasma Fractionation and Blood Product Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 37. Global Plasma Fractionation and Blood Product Sales by Application (2016-2021) (K Units)
    Table 38. Global Plasma Fractionation and Blood Product Sales Share by Application (2016-2021)
    Table 39. Global Plasma Fractionation and Blood Product Revenue by Application (2016-2021) (US$ Million)
    Table 40. Global Plasma Fractionation and Blood Product Revenue Share by Application (2016-2021)
    Table 41. Plasma Fractionation and Blood Product Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 42. Global Plasma Fractionation and Blood Product Sales Forecast by Application (2022-2027) & (K Units)
    Table 43. Global Plasma Fractionation and Blood Product Sales Market Share Forecast by Application (2022-2027)
    Table 44. Global Plasma Fractionation and Blood Product Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 45. Global Plasma Fractionation and Blood Product Revenue Market Share Forecast by Application (2022-2027)
    Table 46. Global Plasma Fractionation and Blood Product Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 47. Japan Plasma Fractionation and Blood Product Sales (K Units) of Key Companies (2016-2021)
    Table 48. Japan Plasma Fractionation and Blood Product Sales Share by Company (2016-2021)
    Table 49. Japan Plasma Fractionation and Blood Product Revenue (US$ Million) by Company (2016-2021)
    Table 50. Japan Plasma Fractionation and Blood Product Revenue Share by Company (2016-2021)
    Table 51. Japan Plasma Fractionation and Blood Product Sales (K Units) by Type (2016-2021)
    Table 52. Japan Plasma Fractionation and Blood Product Sales Share by Type (2016-2021)
    Table 53. Japan Plasma Fractionation and Blood Product Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 54. Japan Plasma Fractionation and Blood Product Price (US$/Unit) by Type (2016-2021)
    Table 55. Japan Plasma Fractionation and Blood Product Sales (K Units) by Type (2022-2027)
    Table 56. Japan Plasma Fractionation and Blood Product Sales Share by Type (2022-2027)
    Table 57. Japan Plasma Fractionation and Blood Product Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 58. Japan Plasma Fractionation and Blood Product Revenue Share by Type (2022-2027)
    Table 59. Japan Plasma Fractionation and Blood Product Price (US$/Unit) by Type (2022-2027)
    Table 60. Japan Plasma Fractionation and Blood Product Sales (K Units) by Application (2016-2021)
    Table 61. Japan Plasma Fractionation and Blood Product Sales Share by Application (2016-2021)
    Table 62. Japan Plasma Fractionation and Blood Product Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 63. Japan Plasma Fractionation and Blood Product Price (US$/Unit) by Application (2016-2021)
    Table 64. Japan Plasma Fractionation and Blood Product Sales (K Units) by Application (2022-2027)
    Table 65. Japan Plasma Fractionation and Blood Product Sales Share by Application (2022-2027)
    Table 66. Japan Plasma Fractionation and Blood Product Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 67. Japan Plasma Fractionation and Blood Product Revenue Share by Application (2022-2027)
    Table 68. Japan Plasma Fractionation and Blood Product Price (US$/Unit) by Application (2022-2027)
    Table 69. North America Plasma Fractionation and Blood Product Sales by Country (2016-2021) & (K Units)
    Table 70. North America Plasma Fractionation and Blood Product Sales Market Share by Country (2016-2021)
    Table 71. North America Plasma Fractionation and Blood Product Revenue by Country (2016-2021) & (US$ Million)
    Table 72. North America Plasma Fractionation and Blood Product Revenue Market Share by Country (2016-2021)
    Table 73. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2016-2021) & (K Units)
    Table 74. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Region (2016-2021)
    Table 75. Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Plasma Fractionation and Blood Product Revenue Market Share by Region (2016-2021)
    Table 77. Europe Plasma Fractionation and Blood Product Sales by Country (2016-2021) & (K Units)
    Table 78. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2016-2021)
    Table 79. Europe Plasma Fractionation and Blood Product Revenue by Country (2016-2021) & (US$ Million)
    Table 80. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country (2016-2021)
    Table 81. Latin America Plasma Fractionation and Blood Product Sales by Country (2016-2021) & (K Units)
    Table 82. Latin America Plasma Fractionation and Blood Product Sales Market Share by Country (2016-2021)
    Table 83. Latin Americaa Plasma Fractionation and Blood Product Revenue by Country (2016-2021) & (US$ Million)
    Table 84. Latin America Plasma Fractionation and Blood Product Revenue Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2016-2021) & (K Units)
    Table 86. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Country (2016-2021)
    Table 87. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2016-2021) & (US$ Million)
    Table 88. Middle East and Africa Plasma Fractionation and Blood Product Revenue Market Share by Country (2016-2021)
    Table 89. Takeda Corporation Information
    Table 90. Takeda Description and Business Overview
    Table 91. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 92. Takeda Plasma Fractionation and Blood Product Product
    Table 93. Takeda Recent Development
    Table 94. CSL Corporation Information
    Table 95. CSL Description and Business Overview
    Table 96. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 97. CSL Product
    Table 98. CSL Recent Development
    Table 99. Grifols Corporation Information
    Table 100. Grifols Description and Business Overview
    Table 101. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 102. Grifols Product
    Table 103. Grifols Recent Development
    Table 104. Octapharma Corporation Information
    Table 105. Octapharma Description and Business Overview
    Table 106. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 107. Octapharma Product
    Table 108. Octapharma Recent Development
    Table 109. Kedrion Corporation Information
    Table 110. Kedrion Description and Business Overview
    Table 111. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 112. Kedrion Product
    Table 113. Kedrion Recent Development
    Table 114. LFB Group Corporation Information
    Table 115. LFB Group Description and Business Overview
    Table 116. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 117. LFB Group Product
    Table 118. LFB Group Recent Development
    Table 119. Biotest Corporation Information
    Table 120. Biotest Description and Business Overview
    Table 121. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 122. Biotest Product
    Table 123. Biotest Recent Development
    Table 124. BPL Corporation Information
    Table 125. BPL Description and Business Overview
    Table 126. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 127. BPL Product
    Table 128. BPL Recent Development
    Table 129. RAAS Corporation Information
    Table 130. RAAS Description and Business Overview
    Table 131. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 132. RAAS Product
    Table 133. RAAS Recent Development
    Table 134. CBPO Corporation Information
    Table 135. CBPO Description and Business Overview
    Table 136. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 137. CBPO Product
    Table 138. CBPO Recent Development
    Table 139. Hualan Bio Corporation Information
    Table 140. Hualan Bio Description and Business Overview
    Table 141. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 142. Hualan Bio Product
    Table 143. Hualan Bio Recent Development
    Table 144. Plasma Fractionation and Blood Product Market Trends
    Table 145. Plasma Fractionation and Blood Product Market Drivers
    Table 146. Plasma Fractionation and Blood Product Market Challenges
    Table 147. Plasma Fractionation and Blood Product Market Restraints
    Table 148. Plasma Fractionation and Blood Product Customers List
    Table 149. Plasma Fractionation and Blood Product Distributors List
    Table 150. Research Programs/Design for This Report
    Table 151. Key Data Information from Secondary Sources
    Table 152. Key Data Information from Primary Sources
List of Figures
    Figure 1. Plasma Fractionation and Blood Product Product Picture
    Figure 2. Global Plasma Fractionation and Blood Product Sales Market Share by Type in 2020 & 2027
    Figure 3. Coagulation Factor Product Picture
    Figure 4. Immune Globulin Product Picture
    Figure 5. Albumin Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Plasma Fractionation and Blood Product Sales Market Share by Application in 2020 & 2027
    Figure 8. Immunology
    Figure 9. Hematology
    Figure 10. Other
    Figure 11. Plasma Fractionation and Blood Product Report Years Considered
    Figure 12. Global Plasma Fractionation and Blood Product Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Plasma Fractionation and Blood Product Market Size 2016-2027 (US$ Million)
    Figure 14. Global Plasma Fractionation and Blood Product Sales 2016-2027 (K Units)
    Figure 15. Global Plasma Fractionation and Blood Product Market Size Market Share by Region: 2021 Versus 2027
    Figure 16. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2016-2021)
    Figure 17. Global Plasma Fractionation and Blood Product Sales Market Share by Region in 2020
    Figure 18. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2016-2021)
    Figure 19. Global Plasma Fractionation and Blood Product Revenue Market Share by Region in 2020
    Figure 20. Global Plasma Fractionation and Blood Product Sales Share by Manufacturer in 2020
    Figure 21. The Top 10 and 5 Players Market Share by Plasma Fractionation and Blood Product Revenue in 2020
    Figure 22. Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 23. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2016-2021)
    Figure 24. Global Plasma Fractionation and Blood Product Sales Market Share by Type in 2020
    Figure 25. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2016-2021)
    Figure 26. Global Plasma Fractionation and Blood Product Revenue Market Share by Type in 2020
    Figure 27. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2016-2021)
    Figure 28. Global Plasma Fractionation and Blood Product Sales Market Share by Application in 2020
    Figure 29. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2016-2021)
    Figure 30. Global Plasma Fractionation and Blood Product Revenue Market Share by Application in 2020
    Figure 31. Japan Plasma Fractionation and Blood Product Sales Growth Rate 2016-2027 (K Units)
    Figure 32. Japan Plasma Fractionation and Blood Product Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 33. Japan Plasma Fractionation and Blood Product Market Share in Global Market 2016-2027
    Figure 34. Japan 5 and 10 Largest Plasma Fractionation and Blood Product Players Market Share by Revenue in Plasma Fractionation and Blood Product in 2020
    Figure 35. Japan Plasma Fractionation and Blood Product Revenue Share by Type (2016-2021)
    Figure 36. Japan Plasma Fractionation and Blood Product Revenue Growth Rate by Type in 2016 & 2020
    Figure 37. Japan Plasma Fractionation and Blood Product Revenue Share by Application (2016-2021)
    Figure 38. Japan Plasma Fractionation and Blood Product Revenue Growth Rate by Application in 2016 & 2020
    Figure 39. North America Plasma Fractionation and Blood Product Sales Growth Rate 2016-2021 (K Units)
    Figure 40. North America Plasma Fractionation and Blood Product Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 41. North America Plasma Fractionation and Blood Product Sales Market Share by Country in 2020
    Figure 42. North America Plasma Fractionation and Blood Product Revenue Market Share by Country in 2020
    Figure 43. United States Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 44. United States Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Canada Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 46. Canada Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 47. Europe Plasma Fractionation and Blood Product Sales Growth Rate 2016-2021 (K Units)
    Figure 48. Europe Plasma Fractionation and Blood Product Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 49. Europe Plasma Fractionation and Blood Product Sales Market Share by Country in 2020
    Figure 50. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country in 2020
    Figure 51. Germany Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 52. Germany Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. France Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 54. France Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. U.K. Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 56. U.K. Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Italy Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 58. Italy Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Russia Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 60. Russia Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 61. Asia Pacific Plasma Fractionation and Blood Product Sales Growth Rate 2016-2021 (K Units)
    Figure 62. Asia Pacific Plasma Fractionation and Blood Product Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 63. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Region in 2020
    Figure 64. Asia Pacific Plasma Fractionation and Blood Product Revenue Market Share by Region in 2020
    Figure 65. China Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 66. China Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. Japan Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 68. Japan Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. South Korea Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 70. South Korea Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. India Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 72. India Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Australia Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 74. Australia Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. China Taiwan Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 76. China Taiwan Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Indonesia Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 78. Indonesia Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Thailand Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 80. Thailand Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Malaysia Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 82. Malaysia Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Latin America Plasma Fractionation and Blood Product Sales Growth Rate 2016-2021 (K Units)
    Figure 84. Latin America Plasma Fractionation and Blood Product Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 85. Latin America Plasma Fractionation and Blood Product Sales Market Share by Country in 2020
    Figure 86. Latin America Plasma Fractionation and Blood Product Revenue Market Share by Country in 2020
    Figure 87. Mexico Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 88. Mexico Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 89. Brazil Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 90. Brazil Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Argentina Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 92. Argentina Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Middle East and Africa Plasma Fractionation and Blood Product Sales Growth Rate 2016-2021 (K Units)
    Figure 94. Middle East and Africa Plasma Fractionation and Blood Product Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 95. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Country in 2020
    Figure 96. Middle East and Africa Plasma Fractionation and Blood Product Revenue Market Share by Country in 2020
    Figure 97. Turkey Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 98. Turkey Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 99. Saudi Arabia Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 100. Saudi Arabia Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. UAE Plasma Fractionation and Blood Product Sales Growth Rate (2016-2021) (K Units)
    Figure 102. UAE Plasma Fractionation and Blood Product Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. Plasma Fractionation and Blood Product Value Chain
    Figure 104. Channels of Distribution
    Figure 105. Distributors Profiles
    Figure 106. Bottom-up and Top-down Approaches for This Report
    Figure 107. Data Triangulation
    Figure 108. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Frequently Asked Questions
Plasma Fractionation and Blood Product report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Plasma Fractionation and Blood Product report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Plasma Fractionation and Blood Product report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports